2 MIN READ

Physician financial transparency reports (Sunshine Act)

Find out how the Sunshine Act helps increase transparency about financial relationships between health care providers and pharmaceutical companies.

Medicare & Medicaid

Membership Moves Medicine™

  • Free access to JAMA Network™ and CME
  • Save hundreds on insurance
  • Fight for physicians and patient rights
Wrapped gift sitting on table
·
3 MIN READ

A medical resident’s guide to gifts from industry

Learn more from the AMA about the ethical and legal standards in this area, and how they apply to medical residents.

Ethics
·
6 MIN READ

AMA guide for media reporting on "open payments" data release

Media should verify the accuracy of data; understand the context of financial relationships between physicians and industry when reporting on open payments data.

Press Releases
·
2 MIN READ

Medicare financial data going public: Review yours now

Physicians have until May 15 to review and dispute reports about financial interactions with manufacturers of drugs and medical devices reported under the the Open Payments program.

Medicare & Medicaid
·
2 MIN READ

AMA overview clarifies CME reporting under the Sunshine Act

The AMA has provided an overview that addresses concerns about reporting requirements and participation in commercially supported, accredited and certified continuing medical education (CME) programs in 2016.

Medicare & Medicaid
·
2 MIN READ

AMA statement on Sunshine Act data release

The AMA is committed to transparency and the availability of information for patients to make informed decisions about their medical care.

Press Releases
·
3 MIN READ

3 answers to know about Sunshine Act data going public

The second release of physicians’ financial data under the Physician Payments Sunshine Act, also known as the Open Payments program, was June 30. Learn the answers to three questions patients or others may ask you about your 2014 financial data.

Medicare & Medicaid
·
2 MIN READ

Review financial data before it goes public in June

Physicians have 45 days to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act. Here’s what you need to know about the process before data is made available to the public in June.

Medicare & Medicaid
·
6 MIN READ

10 top issues that impacted physicians in 2014

A number of regulatory, public health and practice issues took center stage for the medical profession this year. See the 10 topics that made some of the biggest waves among the physician community in 2014—and learn how they played out.

Medicare & Medicaid